These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 6104919

  • 21. Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab.
    Pierik M, Vermeire S, Steen KV, Joossens S, Claessens G, Vlietinck R, Rutgeerts P.
    Aliment Pharmacol Ther; 2004 Aug 01; 20(3):303-10. PubMed ID: 15274667
    [Abstract] [Full Text] [Related]

  • 22. Drug management of inflammatory bowel disease.
    McCarthy CF.
    Ir Med J; 1983 May 01; 76(5):260-2. PubMed ID: 6135675
    [No Abstract] [Full Text] [Related]

  • 23. Autonomic cardiovascular regulation in quiescent ulcerative colitis and Crohn's disease.
    Coruzzi P, Castiglioni P, Parati G, Brambilla V, Brambilla L, Gualerzi M, Cademartiri F, Franzè A, De Angelis G, Di Rienzo M, Di Mario F.
    Eur J Clin Invest; 2007 Dec 01; 37(12):964-70. PubMed ID: 18036030
    [Abstract] [Full Text] [Related]

  • 24. A comparison of autonomic function in patients with inflammatory bowel disease and in healthy controls.
    Ganguli SC, Kamath MV, Redmond K, Chen Y, Irvine EJ, Collins SM, Tougas G.
    Neurogastroenterol Motil; 2007 Dec 01; 19(12):961-7. PubMed ID: 17931336
    [Abstract] [Full Text] [Related]

  • 25. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
    Schinzari F, Armuzzi A, De Pascalis B, Mores N, Tesauro M, Melina D, Cardillo C.
    Clin Pharmacol Ther; 2008 Jan 01; 83(1):70-6. PubMed ID: 17507924
    [Abstract] [Full Text] [Related]

  • 26. Therapy of inflammatory bowel disease, including use of immunosuppressive agents.
    Korelitz BI.
    Clin Gastroenterol; 1980 May 01; 9(2):331-49. PubMed ID: 6104550
    [No Abstract] [Full Text] [Related]

  • 27. Serum zinc and taste acuity in Tel-Aviv patients with inflammatory bowel disease.
    Tiomny E, Horwitz C, Graff E, Rozen P, Gilat T.
    Am J Gastroenterol; 1982 Feb 01; 77(2):101-4. PubMed ID: 7072676
    [Abstract] [Full Text] [Related]

  • 28. Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease.
    Korelitz BI, Present DH, Rubin PH, Fochios SE.
    J Clin Gastroenterol; 1984 Feb 01; 6(1):27-31. PubMed ID: 6142067
    [Abstract] [Full Text] [Related]

  • 29. [Determination of sulfapyridine levels in serum--a possibility for the control of dose related therapy with sulfasalazine].
    Eitner K, Reinicke C, Hippius M.
    Dtsch Z Verdau Stoffwechselkr; 1984 Feb 01; 44(6):282-8. PubMed ID: 6151895
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Chronic idiopathic enterocolitis and pregnancy. Reciprocal repercussions and treatment].
    Cléandre D, Dufour P, Tiberghien B, Bernardi C, Vinatier D, Monnier JC.
    J Gynecol Obstet Biol Reprod (Paris); 1993 Feb 01; 22(1):59-65. PubMed ID: 8096531
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.
    Frøslie KF, Jahnsen J, Moum BA, Vatn MH, IBSEN Group.
    Gastroenterology; 2007 Aug 01; 133(2):412-22. PubMed ID: 17681162
    [Abstract] [Full Text] [Related]

  • 35. Measurement of rectal blood flow by laser Doppler flowmetry in inflammatory bowel disease.
    Guslandi M, Sorghi S, Polli D, Tittobello A.
    Hepatogastroenterology; 1998 Aug 01; 45(20):445-6. PubMed ID: 9638422
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Immunomodulation treatment of inflammatory bowel disease].
    Stave R.
    Tidsskr Nor Laegeforen; 1984 Jan 30; 104(3):153-4. PubMed ID: 6142543
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.